Foresite Capital Management V’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,403,276
Closed -$7.86M 9
2023
Q2
$7.86M Sell
3,403,276
-113,196
-3% -$320K 5.74% 7
2023
Q1
$8.97M Hold
3,516,472
6.63% 7
2022
Q4
$8.83M Hold
3,516,472
6.86% 6
2022
Q3
$10.2M Hold
3,516,472
7.84% 6
2022
Q2
$15.9M Sell
3,516,472
-210,000
-6% -$1.25M 11.1% 4
2022
Q1
$29.9M Sell
3,726,472
-1,600,000
-30% -$14.1M 12.2% 3
2021
Q4
$62M Hold
5,326,472
15.23% 2
2021
Q3
$66M Buy
+5,326,472
New +$60.1M 20.51% 1

Other funds holding SLGC

Foresite Capital Management V's SLGC Position: Q3 2023 in Review

Foresite Capital Management V sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q3 2023, closing a stake of 3,403,276 shares — an estimated $7.86M sold.

Foresite Capital Management V first reported a position in SLGC in Q3 2021 and held it in 8 quarters. The position peaked at $66M in Q3 2021. 118 funds tracked by Wall St. Rank hold SLGC as of Q3 2023.

  • Foresite Capital Management V reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Foresite Capital Management V sold 3,403,276 SomaLogic, Inc. Class A Common Stock shares in Q3 2023, an estimated $7.86M.
  • Foresite Capital Management V first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 8 quarters.
  • Foresite Capital Management V's SomaLogic, Inc. Class A Common Stock position peaked at $66M in Q3 2021.
  • 118 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q3 2023.

Based on Foresite Capital Management V's 13F filing for Q3 2023, filed 13 Nov 2023.